Immuneering - Class A (IMRX)'s 30-day implied volatility (IV30) was 49.4% at the close on October 20, 2026, up from 46.0% the day before, against a 52-week range of 46.0% to 221.8%. Its 20-day historical volatility was 56.1%.
Data as of October 20, 2026.